Cervical cancer survivors and health care use: A Danish population-based register study

Research output: Contribution to journalJournal articlepeer-review

Standard

Cervical cancer survivors and health care use : A Danish population-based register study. / Skorstengaard, Malene; Frederiksen, Maria Eiholm; Baillet, Miguel Vázquez Prada; Beau, Anna Belle; Jensen, Pernille Tine; Rygaard, Carsten; Hallas, Jesper; Lynge, Elsebeth.

In: Gynecologic Oncology, Vol. 161, No. 2, 2021, p. 565-572.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Skorstengaard, M, Frederiksen, ME, Baillet, MVP, Beau, AB, Jensen, PT, Rygaard, C, Hallas, J & Lynge, E 2021, 'Cervical cancer survivors and health care use: A Danish population-based register study', Gynecologic Oncology, vol. 161, no. 2, pp. 565-572. https://doi.org/10.1016/j.ygyno.2021.02.003

APA

Skorstengaard, M., Frederiksen, M. E., Baillet, M. V. P., Beau, A. B., Jensen, P. T., Rygaard, C., Hallas, J., & Lynge, E. (2021). Cervical cancer survivors and health care use: A Danish population-based register study. Gynecologic Oncology, 161(2), 565-572. https://doi.org/10.1016/j.ygyno.2021.02.003

Vancouver

Skorstengaard M, Frederiksen ME, Baillet MVP, Beau AB, Jensen PT, Rygaard C et al. Cervical cancer survivors and health care use: A Danish population-based register study. Gynecologic Oncology. 2021;161(2):565-572. https://doi.org/10.1016/j.ygyno.2021.02.003

Author

Skorstengaard, Malene ; Frederiksen, Maria Eiholm ; Baillet, Miguel Vázquez Prada ; Beau, Anna Belle ; Jensen, Pernille Tine ; Rygaard, Carsten ; Hallas, Jesper ; Lynge, Elsebeth. / Cervical cancer survivors and health care use : A Danish population-based register study. In: Gynecologic Oncology. 2021 ; Vol. 161, No. 2. pp. 565-572.

Bibtex

@article{e112b86f3b2146169c9fa517646f6a48,
title = "Cervical cancer survivors and health care use: A Danish population-based register study",
abstract = "Objective: To evaluate the impact of a cervical cancer (CC) diagnosis on use of health care and prescription drugs. Methods: This population-based register-study included Danish women aged 23–59 years and diagnosed with CC in 2001–2005. Women with a cervical screening outcome were used as comparison group. We obtained number of contacts to general practitioners (GPs), hospitals, psychologists/psychiatrists and defined daily doses (DDD) of analgesic/psychotropic prescription drugs. A difference-in-differences-design was used to estimate effect of a CC diagnosis on health-care use from five-year periods before and after the diagnosis/screening outcome. Results: In total, 926 women with CC and 1,004,759 women without cancer were included. In five years following the date of CC diagnosis, CC patients had increased their use of GPs with 8.6 (95% CI 4.8–12.4) contacts more than women in the comparison group, and with 4.12 (95% CI 3.99–4.25) more hospital contacts. In contrast, use of psychologists/psychiatrists was low and largely unaffected by the CC diagnosis. For use of prescription drugs, analgesics increased with 80 (95% CI 60–100) DDD more in CC patients than in comparison women, and for psychotropics with 304 (95% CI 261–347) DDD more. Conclusions: A CC diagnosis was followed by an increase in use of GPs, hospitals, and analgesic/psychotropic prescription drugs, while use of psychologist/psychiatrist was largely unaffected. This pattern may indicate that pain/mental health concerns after CC either persisted or were alleviated by other means only.",
keywords = "Cervical cancer, General practitioners, Hospitals, Prescription drugs, Psychiatrists, Psychologists",
author = "Malene Skorstengaard and Frederiksen, {Maria Eiholm} and Baillet, {Miguel V{\'a}zquez Prada} and Beau, {Anna Belle} and Jensen, {Pernille Tine} and Carsten Rygaard and Jesper Hallas and Elsebeth Lynge",
note = "Publisher Copyright: {\textcopyright} 2021 The Authors",
year = "2021",
doi = "10.1016/j.ygyno.2021.02.003",
language = "English",
volume = "161",
pages = "565--572",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press",
number = "2",

}

RIS

TY - JOUR

T1 - Cervical cancer survivors and health care use

T2 - A Danish population-based register study

AU - Skorstengaard, Malene

AU - Frederiksen, Maria Eiholm

AU - Baillet, Miguel Vázquez Prada

AU - Beau, Anna Belle

AU - Jensen, Pernille Tine

AU - Rygaard, Carsten

AU - Hallas, Jesper

AU - Lynge, Elsebeth

N1 - Publisher Copyright: © 2021 The Authors

PY - 2021

Y1 - 2021

N2 - Objective: To evaluate the impact of a cervical cancer (CC) diagnosis on use of health care and prescription drugs. Methods: This population-based register-study included Danish women aged 23–59 years and diagnosed with CC in 2001–2005. Women with a cervical screening outcome were used as comparison group. We obtained number of contacts to general practitioners (GPs), hospitals, psychologists/psychiatrists and defined daily doses (DDD) of analgesic/psychotropic prescription drugs. A difference-in-differences-design was used to estimate effect of a CC diagnosis on health-care use from five-year periods before and after the diagnosis/screening outcome. Results: In total, 926 women with CC and 1,004,759 women without cancer were included. In five years following the date of CC diagnosis, CC patients had increased their use of GPs with 8.6 (95% CI 4.8–12.4) contacts more than women in the comparison group, and with 4.12 (95% CI 3.99–4.25) more hospital contacts. In contrast, use of psychologists/psychiatrists was low and largely unaffected by the CC diagnosis. For use of prescription drugs, analgesics increased with 80 (95% CI 60–100) DDD more in CC patients than in comparison women, and for psychotropics with 304 (95% CI 261–347) DDD more. Conclusions: A CC diagnosis was followed by an increase in use of GPs, hospitals, and analgesic/psychotropic prescription drugs, while use of psychologist/psychiatrist was largely unaffected. This pattern may indicate that pain/mental health concerns after CC either persisted or were alleviated by other means only.

AB - Objective: To evaluate the impact of a cervical cancer (CC) diagnosis on use of health care and prescription drugs. Methods: This population-based register-study included Danish women aged 23–59 years and diagnosed with CC in 2001–2005. Women with a cervical screening outcome were used as comparison group. We obtained number of contacts to general practitioners (GPs), hospitals, psychologists/psychiatrists and defined daily doses (DDD) of analgesic/psychotropic prescription drugs. A difference-in-differences-design was used to estimate effect of a CC diagnosis on health-care use from five-year periods before and after the diagnosis/screening outcome. Results: In total, 926 women with CC and 1,004,759 women without cancer were included. In five years following the date of CC diagnosis, CC patients had increased their use of GPs with 8.6 (95% CI 4.8–12.4) contacts more than women in the comparison group, and with 4.12 (95% CI 3.99–4.25) more hospital contacts. In contrast, use of psychologists/psychiatrists was low and largely unaffected by the CC diagnosis. For use of prescription drugs, analgesics increased with 80 (95% CI 60–100) DDD more in CC patients than in comparison women, and for psychotropics with 304 (95% CI 261–347) DDD more. Conclusions: A CC diagnosis was followed by an increase in use of GPs, hospitals, and analgesic/psychotropic prescription drugs, while use of psychologist/psychiatrist was largely unaffected. This pattern may indicate that pain/mental health concerns after CC either persisted or were alleviated by other means only.

KW - Cervical cancer

KW - General practitioners

KW - Hospitals

KW - Prescription drugs

KW - Psychiatrists

KW - Psychologists

U2 - 10.1016/j.ygyno.2021.02.003

DO - 10.1016/j.ygyno.2021.02.003

M3 - Journal article

C2 - 33618844

AN - SCOPUS:85101057473

VL - 161

SP - 565

EP - 572

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -

ID: 262938978